Agency: Drug Enforcement Administration
Years: 20002001200220032004200520062007200820092010201120122013[FR Doc 04-27839] 1. Agency Information Collection Activities: Proposed Collection; Comments
The Department of Justice (DOJ), Drug Enforcement Administration (DEA), has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and
Published: 2004-12-21 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 04-27449] 2. Exemption of Chemical Mixtures
On September 16, 1998, the Drug Enforcement Administration (DEA) published a Notice of Proposed Rulemaking (NPRM) (63 FR 49506) that proposed new regulations concerning chemical mixtures that contain any of the 34 listed chemicals subject to DEA control at that time. The NPRM was the initial step toward implementation of Controlled Substances Act
Published: 2004-12-15 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 04-27317] 3. Agency Information Collection Activities: Proposed Collection; Comments
The Department of Justice (DOJ), Drug Enforcement Administration (DEA), has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and
Published: 2004-12-14 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 04-27337] 4. Agency Information Collection Activities: Proposed Collection; Comments
The Department of Justice (DOJ), Drug Enforcement Administration (DEA), has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and
Published: 2004-12-14 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 04-26808] 5. Clarification of Registration Requirements for Individual Practitioners
The Drug Enforcement Administration (DEA) proposes to amend its registration regulations to make it clear that when an individual practitioner who practices and is registered in one state seeks to practice and prescribe controlled substances in another state, he/she must obtain a separate DEA registration for the subsequent state. The current
Published: 2004-12-07 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 04-26737] 6. Manufacturer of Controlled Substances; Notice of Application
Pursuant to section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on August 19, 2004, Organichem, Corporation, 33 Riverside Avenue, Rensselaer, New York 12144, made application by renewal to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled
Published: 2004-12-06 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 04-26734] 7. Manufacturer of Controlled Substances; Notice of Application; Correction
By Notice dated June 28, 2004, and published in the Federal Register on July 13, 2004, (69 FR 4206742068), dated April 29 2004, the listing of controlled substances for Oxycodone (9143) and Hydrocodone (9193), were inadvertently omitted, by Cedarburg Pharmaceuticals, Inc., 870 Badger Circle, Grafton, Wisconsin 53024.
Dated: November 22,
Published: 2004-12-06 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 04-26735] 8. Importation of Controlled Substances; Notice of Application
Pursuant to 21 U.S.C. 958(1)), the Attorney General shall, prior to issuing a registration under this Section to a bulk manufacturer of a controlled substance in Schedule I or II and prior to issuing a registration under 21 U.S.C. 952 (a)(2)(b) authorizing the importation of such substances, provide manufacturers holding registrations for the
Published: 2004-12-06 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 04-26736] 9. Manufacturer of Controlled Substances; Notice of Application
Pursuant to section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on September 20, 2004, Johnson Matthey, Inc., Custom Pharmaceuticals Department, 2003 Nolte Drive, West Deptford, New Jersey 08066, made application by renewal to the Drug Enforcement Administration (DEA) for registration as a bulk
Published: 2004-12-06 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 04-26689] 10. Controlled Substances: Proposed Aggregate Production Quotas for 2005
This notice proposes initial year 2005 aggregate production quotas for controlled substances in Schedules I and II of the Controlled Substances Act (CSA).
Published: 2004-12-03 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 04-26306] 11. Deborah Bordeaux, M.D.; Revocation of Registration
On June 8, 2001, the Administrator of the Drug Enforcement Administration (DEA), issued an Order to Show Cause/Immediate Suspension of Registration to Deborah Bordeaux, M.D. (Dr. Bordeaux), notifying her of an opportunity to show cause as to why DEA should not revoke her DEA Certificate of Registration, BB3869370, as a practitioner, pursuant
Published: 2004-11-29 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 04-26309] 12. CWK Enterprises, Inc.; Denial of Registration
On July 23, 2004, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration (DEA), issued an Order to Show Cause to CWK Enterprises, Inc. (CWK) proposing to deny its March 1, 2003, application for DEA Certificate of Registration as a distributor of list I chemicals. The Order to Show Cause alleged that
Published: 2004-11-29 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 04-26310] 13. Dan E. Hale, D.O., Denial of Registration
On March 21, 2002, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration (DEA), issued an Order to Show Cause to Dan E. Hale, D.O. (Respondent) notifying Respondent of an opportunity to show cause as to why DEA should not deny his application for a DEA Certificate of Registration as a practitioner
Published: 2004-11-29 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 04-26311] 14. Prachi Enterprises, Inc.; Denial of Registration
On July 23, 2004, the Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement Administration (DEA), issued an
Order to Show Cause to Prachi Enterprises, Inc. (Prachi) proposing to deny its September 9, 2003, application for DEA
[[Page 69408]]
Certificate of Registration as a distributor of list I chemicals. The
Order to
Published: 2004-11-29 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 04-26312] 15. Volusia Wholesale; Denial of Registration
On July 23, 2004, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration (DEA), issued an Order to Show Cause to Volusia Wholesale (Volusia) proposing to deny its December 12, 2003, application for DEA Certificate of Registration as a distributor of list I chemicals. The Order to Show Cause alleged
Published: 2004-11-29 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 04-25695] 16. Indace, Inc., c/o Seegott, Inc.; Malladi, Inc.; Suspension of Shipments
On January 25, 2001, the thenAdministrator of the Drug Enforcement Administration (DEA) issued an Order to Suspend Shipment to Indace, Inc., c/o Seegot, Inc. (Indace) of Elgin, Illinois, notifying it that pursuant to 21 U.S.C. 971, DEA had ordered the suspension of a shipment of 3,000 kilograms of ephedrine hydrochloride, a listed chemical,
Published: 2004-11-22 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 04-25767] 17. Manufacturer of Controlled Substances; Notice of Application
Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on August 19, 2004, ISP,
Freetown Fine Chemicals, Inc., 238 South Main Street, Assonet, Massachusetts 02702, made application
[[Page 67963]]
by renewal to the Drug Enforcement Administration (DEA) for
registration as a bulk manufacturer of
Published: 2004-11-22 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 04-25768] 18. Importer of Controlled Substances; Notice of Application
Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to issuing a registration under this Section to a bulk manufacturer of a controlled substance in Schedule I or II and prior to issuing a registration under 21 U.S.C. 952(a)(2)(B) authorizing the importation of such a substance, provide manufacturers holding registrations for the
Published: 2004-11-22 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 04-25769] 19. Manufacturer of Controlled Substances; Notice of Application
Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on September 28, 2004, Orasure Technologies, Inc., Lehigh University, Seeley G. MuddBuilding 6, Bethlehem, Pennsylvania 18015, made application by renewal to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer
Published: 2004-11-22 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 04-25694] 20. Nilvio R. Aquino, M.D. Revocation of Registration
On February 25, 2002, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration (DEA), issued an Order to Show Cause to Nilvio R. Aquino, M.D. (Dr. Aquino) who was notified of an opportunity to show cause as to why DEA should not revoke his DEA Certificate of Registration AA1153991, under 21 U.S.C.
Published: 2004-11-19 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 04-25469] 21. Dispensing of Controlled Substances for the Treatment of Pain
In August 2004, DEA published on its Office of Diversion Control Web site a document entitled: ``Prescription Pain Medications: Frequently Asked Questions and Answers for Health Care Professionals and Law Enforcement Personnel'' (August 2004 FAQ). The August 2004 FAQ was not published in the Federal Register and was not an official statement of
Published: 2004-11-16 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 04-25340] 22. Controlled Substances: Final Revised Aggregate Production Quotas for 2004
This notice establishes final 2004 aggregate production quotas for controlled substances in Schedules I and II of the Controlled Substances Act (CSA). The DEA has taken into consideration comments received in response to a notice of the proposed revised aggregate production quotas for 2004 published September 9, 2004 (69 FR 54703).
Published: 2004-11-16 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 04-25171] 23. Agency Information Collection Activities: Proposed Collection; Comments
The Department of Justice (DOJ), Drug Enforcement Administration (DEA), has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and
Published: 2004-11-12 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 04-25103] 24. Manufacturer of Controlled Substances; Notice of Registration
By Notice dated May 21, 2004, and published in the Federal Register on June 3, 2004, (69 FR 31411), American Radiolabeled Chemicals, Inc., 101 Arc Drive, St. Louis, Missouri 63146, made application by renewal to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed
Published: 2004-11-10 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 04-25104] 25. Manufacturer of Controlled Substances; Notice of Application
Pursuant to 21 CFR 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on July 28, 2004, Guilford Pharmaceuticals, Inc., 6611 Tributary Street, Baltimore, Maryland 21224, made application by renewal to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of Cocaine (9041), a basic
Published: 2004-11-10 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
Years: 20002001200220032004200520062007200820092010201120122013